Julia Cohen-Grinshpun
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Letters to Editor: The risk for clinically significant copy number variants in pregnancies with two soft markers, Geriatriophobia - a new concept in the medical world in Israel
Journal: Harefuah
Published: December 18, 2024
Dystrophinopathy patient data as a guide to interpretation of pregestational female population screening for DMD gene variants.
Journal: Neurogenetics
Published: August 06, 2024
THE RISK FOR CLINICALLY SIGNIFICANT COPY NUMBER VARIANTS IN PREGNANCIES WITH TWO SOFT MARKERS
Journal: Harefuah
Published: June 17, 2024
MOH SCREENING FOR TBCD IN COCHIN JEWS: COLLABORATION BETWEEN MEDICAL, RESEARCH AND COMMUNITY MEMBERS IN ACHIEVING PUBLIC HEALTH GOALS
Journal: Harefuah
Published: July 02, 2023
SUMMARY AND UPDATES IN THE FIELD OF GENETIC TESTING IN ISRAEL - AS OF 2022
Journal: Harefuah
Published: July 02, 2023
Lessons learned from the first national population-based genetic carrier-screening program for Duchenne muscular dystrophy.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: January 20, 2023
A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies.
Journal: Scientific reports
Published: April 15, 2021
Colchicine treatment increases the risk for fetal chromosomal aberrations-an observational study and systematic literature review.
Journal: Rheumatology (Oxford, England)
Published: May 30, 2020
Chromosomal Microarray Analysis Results From Pregnancies With Various Ultrasonographic Anomalies.
Journal: Obstetrics and gynecology
Published: November 07, 2018
The limited effect of information on Israeli pregnant women at advanced maternal age who decide to undergo amniocentesis.
Journal: Israel journal of health policy research
Published: October 15, 2014
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 07, 2014
Last Updated: 09/26/2026